💉Mounjaro, Ozempic & Semaglutide: Blood Tests in India
Starting a GLP-1 injection in 2026? Here is the baseline and 3-month lab panel — HbA1c, LFT, kidney, lipids, lipase — and which results mean call your doctor today.
Scanura Editorial
Health Education Team
Written by Scanura Editorial for health education. This article is not a substitute for advice from a qualified doctor. About our editorial standards
Mounjaro, Ozempic & Semaglutide in India: Blood Tests Before and During GLP-1
Someone in the family started a weekly injection after seeing a gym reel. A cousin is on a semaglutide generic that costs a fraction of last year’s branded pen. Your own doctor mentioned Mounjaro (tirzepatide) or Ozempic / Wegovy (semaglutide) because of diabetes or obesity. The prescription pad also lists a baseline blood panel — and you are not sure which numbers actually matter.
GLP-1 and dual GIP/GLP-1 medicines became India’s loudest health search theme of 2026 after the semaglutide patent cliff and a wave of domestic generics. This article is not a how-to-buy guide and not permission to start injections. It is a 2026 lab-monitoring explainer: which tests clinicians commonly check before the first dose, what to repeat at 3 months, and which red-flag results mean you should call the prescribing doctor the same day.
Related reading: HbA1c, LFT / SGPT, amylase and lipase, creatinine and eGFR, lipid profile.
What These Medicines Are (Plain Language)
GLP-1 receptor agonists (semaglutide, liraglutide, dulaglutide) and tirzepatide (GIP + GLP-1) mimic gut hormones that:
- increase insulin when glucose is high
- slow stomach emptying (you feel full sooner)
- reduce appetite in the brain
In India they are prescription-only. Typical licensed uses are type 2 diabetes and, for some brands/doses, chronic weight management when BMI and comorbidity rules are met. Indian / Asian BMI cut-offs used in clinic are often lower than Western posters (overweight from BMI ~23; obesity treatment discussions often from ~27.5, or ~25 with metabolic disease — your endocrinologist applies the label in front of them).
| Name you hear | Generic | Usual role (labels differ — follow your pack insert) |
|---|---|---|
| Ozempic | Semaglutide (injection) | Type 2 diabetes (branded) |
| Wegovy | Semaglutide (higher weight-management doses) | Obesity (where approved) |
| Rybelsus | Oral semaglutide | Type 2 diabetes |
| Indian semaglutide pens / vials | Generic semaglutide | Diabetes / as prescribed after 2026 launches |
| Mounjaro | Tirzepatide | Type 2 diabetes and obesity indications where approved |
They are not vitamins. Compounded “research” vials, sharing pens, and skipping the doctor because a generic is cheap are how people end up with gallbladder pain, severe dehydration, or untreated pancreatitis.
Blood Tests Commonly Done Before the First Dose
A responsible baseline is about safety and a starting line, not about “passing” a test to buy the drug.
| Test | Why it is ordered | What you are looking for educationally |
|---|---|---|
| HbA1c + fasting glucose | Confirms diabetes control; sets the 3-month comparison | Diabetes diagnosis and treatment response live here |
| Creatinine + eGFR | Dosing, dehydration risk, metformin combo | Falling eGFR or AKI risk needs a plan |
| LFT (SGPT/ALT, SGOT/AST, bilirubin) | Fatty liver is common; GI side effects plus enzyme rise need context | Mild fatty-liver enzyme bumps vs a new spike after starting |
| Lipid profile | Metabolic health; weight loss often improves triglycerides | Baseline for 3–6 month change |
| Amylase / lipase | If there is a history of pancreatitis, heavy alcohol, or unexplained abdominal pain | Not always mandatory for every patient — clinician call |
| TSH | Unexplained weight change can be thyroid, not “just obesity” | Treat thyroid disease properly; GLP-1 is not a thyroid pill |
| Pregnancy test (if applicable) | These drugs are not for pregnancy | Stop and call the prescriber if pregnancy is possible |
| CBC | General fitness for treatment | Anaemia, infection clues |
People with type 2 diabetes often already have this panel yearly. Starting GLP-1 is a reason to repeat a fresh baseline, not to reuse a 14-month-old checkup.
If PCOS or fatty liver is part of the story, those are comorbidities, not a separate secret indication. Insulin resistance tests: fasting insulin / HOMA-IR. Fatty liver grades: ultrasound + LFT.
Monitoring While You Are On Treatment
There is no single ICMR spreadsheet that every clinic follows. A practical rhythm many Indian endocrinology clinics use:
| Timing | Typical labs | Why |
|---|---|---|
| Week 0 | Full baseline above | Safety + starting line |
| ~4 weeks | Not always bloods — symptoms (vomiting, pain, hydration) | Early GI effects; kidney injury from dehydration |
| ~12 weeks | HbA1c, LFT, creatinine/eGFR, lipids | Did glucose improve? Did enzymes or kidneys change? |
| Every 3–6 months once stable | HbA1c (diabetes), kidney, liver as indicated | Maintenance |
| Any severe abdominal pain | Lipase/amylase, LFT, clinical exam ± ultrasound | Rule out pancreatitis / gallbladder disease |
Weight on the scale is not a blood test, but it belongs on the same follow-up card as HbA1c. Rapid loss plus fatigue should trigger CBC, ferritin, B12 if diet has collapsed to tea and biscuits — muscle and micronutrients still matter.
What “success” looks like on paper
| Marker | Educational expectation |
|---|---|
| HbA1c | Often falls over 8–12 weeks if the indication is diabetes — magnitude is individual |
| Triglycerides | May improve with weight and glucose |
| SGPT | May drift down if liver fat falls; a new sharp rise is not “normal adjustment” |
| Creatinine | Should not climb because you stopped drinking water during nausea |
Side Effects That Show Up on Labs (or Should Trigger Labs)
| Problem | What you may notice | Labs / action |
|---|---|---|
| Dehydration from vomiting/diarrhoea | Dizziness, low urine | Creatinine can jump — acute kidney injury; fluids + call doctor |
| Gallbladder disease | Right-upper pain after fatty food | Ultrasound; LFT pattern |
| Pancreatitis (uncommon, serious) | Severe persistent upper abdominal pain, vomiting | Lipase/amylase — emergency, stop drug as instructed |
| Galloping glucose drop (if also on sulfonylurea/insulin) | Sweating, confusion | Glucose; medication review — not more GLP-1 |
| Muscle loss / “sagging” | Weakness despite weight loss | Not a single lab; protein intake + resistance exercise as advised |
| Thyroid symptoms | Neck mass, hoarseness (rare personal-history discussions) | Clinical — personal/family MTC history is a pre-prescription question, not a DIY blood test |
B12: GLP-1 itself is not the classic B12 thief; long-term metformin is. If you take both, periodic B12 still makes sense.
India-Specific Reality Check (2026)
- Generics are not a different biology. Cheaper semaglutide is still a prescription hormone analogue. Counterfeit pens are a documented global risk — use a licensed pharmacy.
- “Thin-fat” Indians (normal BMI, high waist, fatty liver, high insulin) need waist, HbA1c, and lipids, not only the weighing scale.
- Aesthetic-clinic packages that skip baseline LFT/kidney/pregnancy testing are a red flag.
- scanura does not prescribe GLP-1. It explains the PDFs you already got.
Cost, brand, and availability change quickly. Your bill is not a lab result. The lab result is whether HbA1c, liver, and kidney are moving in a safe direction.
How to Use Your Reports With scanura
Upload baseline and 3-month PDFs together when you have them. scanura can walk through HbA1c, SGPT, creatinine/eGFR, and lipids in Hindi or English so you can ask the prescriber: “Is this expected, or do we pause?” Create an account if you do not have one.
Do not upload a friend’s report and copy their dose.
When to Worry — Call the Prescribing Doctor or Emergency
| Situation | Action |
|---|---|
| Severe abdominal pain that does not settle | Emergency evaluation for pancreatitis / gallbladder |
| Persistent vomiting, almost no urine | Kidney risk — same day |
| Pregnancy or missed period | Stop per clinician advice immediately |
| Allergic swelling, trouble breathing | Emergency |
| HbA1c or sugars unexpectedly very low on other diabetes drugs | Urgent dose review |
| SGPT or bilirubin rising fast | Do not wait for the next “package deal” |
Key Takeaways
- GLP-1 and tirzepatide are prescription medicines — generics in 2026 changed price, not the need for a doctor.
- Baseline labs typically include HbA1c, kidney function, LFT, and lipids; add lipase, TSH, CBC, and pregnancy testing when the story requires it.
- Repeat key tests around 12 weeks — that is when glucose and liver-fat trends are readable.
- Vomiting can injure kidneys through dehydration; creatinine is part of safety, not a weight-loss trophy.
- Severe abdominal pain is a stop-and-get-help symptom, not a “normal week-1 gas” story.
- These drugs are not for pregnancy.
- Success is HbA1c, waist, and safe labs — not only the smallest number on the scale.
- Upload serial reports to scanura to compare 0-week and 12-week PDFs in plain language before your endocrinology visit.
Disclaimer: This article is for educational purposes only. scanura does not provide medical diagnosis and does not prescribe or supply GLP-1 medicines. Always consult your doctor for medical decisions.
Medical References
Step-by-Step Guide
- 1
Only start under a licensed prescriber
Generics changed price in 2026, not the need for a prescription and a baseline exam.
- 2
Get baseline HbA1c, creatinine/eGFR, LFT, and lipids
Add lipase, TSH, CBC, and a pregnancy test when your clinician asks.
- 3
Treat nausea as a kidney risk, not a badge of honour
Vomiting plus poor fluids can raise creatinine — call if urine output drops.
- 4
Repeat key labs around 12 weeks
That is when HbA1c and liver-fat trends are readable versus week-0.
- 5
Stop and seek emergency care for severe abdominal pain
Pancreatitis and gallbladder disease are uncommon but not 'normal gas'.
- 6
Upload week-0 and week-12 PDFs together
Serial comparison beats reading one isolated number.
📬 One health report guide, every week
Normal ranges, what your values mean, and what to ask your doctor — in plain language. Free, unsubscribe anytime.